1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Mental Health Market Trends
  5. > Obsessive-Compulsive Disorder Global Clinical Trials Review, H2, 2016

Obsessive-Compulsive Disorder Global Clinical Trials Review, H2, 2016

Summary

GlobalData's clinical trial report, “Obsessive-Compulsive Disorder Global Clinical Trials Review, H2, 2016" provides an overview of Obsessive-Compulsive Disorder clinical trials scenario. This report provides top line data relating to the clinical trials on Obsessive-Compulsive Disorder. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table Of Contents

Obsessive-Compulsive Disorder Global Clinical Trials Review, H2, 2016
Table of Contents
Table of Contents 2


Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Middle East and Africa 12
Top Countries Contributing to Clinical Trials in Central and South America 13
Clinical Trials by G7 Countries: Proportion of Obsessive-Compulsive Disorder to Central Nervous System Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Obsessive-Compulsive Disorder to Central Nervous System Clinical Trials 17
Clinical Trials by Phase in E7 Countries 18
Clinical Trials in E7 Countries by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Clinical Trials by End Point Status 23
Subjects Recruited Over a Period of Time 24
Clinical Trials by Sponsor Type 25
Prominent Sponsors 26
Top Companies Participating in Obsessive-Compulsive Disorder Therapeutics Clinical Trials 27
Prominent Drugs 28
Clinical Trial Profile Snapshots 29
Appendix 156
Abbreviations 156
Definitions 156
Research Methodology 157
Secondary Research 157
About GlobalData 158
Contact Us 158
Disclaimer 158
Source 159

List of Tables
Obsessive-Compulsive Disorder Therapeutics, Global, Clinical Trials by Region, 2016* 6
Obsessive-Compulsive Disorder Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7
Obsessive-Compulsive Disorder Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8
Obsessive-Compulsive Disorder Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016* 9
Obsessive-Compulsive Disorder Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 10
Obsessive-Compulsive Disorder Therapeutics Clinical Trials, North America, Top Countries, 2016* 11
Obsessive-Compulsive Disorder Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2016* 12
Obsessive-Compulsive Disorder Therapeutics Clinical Trials, Central and South America, Top Countries, 2016* 13
Proportion of Obsessive-Compulsive Disorder to Central Nervous System Clinical Trials, G7 Countries (%), 2016* 14
Obsessive-Compulsive Disorder Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 15
Obsessive-Compulsive Disorder Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 16
Proportion of Obsessive-Compulsive Disorder to Central Nervous System Clinical Trials, E7 Countries (%), 2016* 17
Obsessive-Compulsive Disorder Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 18
Obsessive-Compulsive Disorder Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 19
Obsessive-Compulsive Disorder Therapeutics, Global, Clinical Trials by Phase, 2016* 20
Obsessive-Compulsive Disorder Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 21
Obsessive-Compulsive Disorder Therapeutics, Global, Clinical Trials by Trial Status, 2016* 22
Obsessive-Compulsive Disorder Therapeutics Clinical Trials, Global, by End Point Status, 2016* 23
Obsessive-Compulsive Disorder Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 24
Obsessive-Compulsive Disorder Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 25
Obsessive-Compulsive Disorder Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 26
Obsessive-Compulsive Disorder Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 27
Obsessive-Compulsive Disorder Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 28

List of Figures
Obsessive-Compulsive Disorder Therapeutics, Global, Clinical Trials by Region (%), 2016* 6
Obsessive-Compulsive Disorder Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7
Obsessive-Compulsive Disorder Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8
Obsessive-Compulsive Disorder Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016* 9
Obsessive-Compulsive Disorder Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 10
Obsessive-Compulsive Disorder Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 11
Obsessive-Compulsive Disorder Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2016* 12
Proportion of Obsessive-Compulsive Disorder to Central Nervous System Clinical Trials, G7 Countries (%), 2016* 14
Obsessive-Compulsive Disorder Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 15
Obsessive-Compulsive Disorder Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 16
Proportion of Obsessive-Compulsive Disorder to Central Nervous System Clinical Trials, E7 Countries (%), 2016* 17
Obsessive-Compulsive Disorder Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 18
Obsessive-Compulsive Disorder Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 19
Obsessive-Compulsive Disorder Therapeutics, Global, Clinical Trials by Phase (%), 2016* 20
Obsessive-Compulsive Disorder Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 21
Obsessive-Compulsive Disorder Therapeutics, Global, Clinical Trials by Trial Status, 2016* 22
Obsessive-Compulsive Disorder Therapeutics Clinical Trials, Global, by End Point Status, 2016* 23
Obsessive-Compulsive Disorder Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 24
Obsessive-Compulsive Disorder Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 25
Obsessive-Compulsive Disorder Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 26
Obsessive-Compulsive Disorder Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 27
Obsessive-Compulsive Disorder Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 28
GlobalData Methodology 157

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Obsessive-Compulsive Disorder - Market Insights, Epidemiology and Market Forecast-2023

Obsessive-Compulsive Disorder - Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • November 2016
  • by Delve Insight

Note*: This report requires 5 business days to complete. DelveInsight’s Obsessive-Compulsive Disorder - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease ...

Obsessive-Compulsive Disorder-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

Obsessive-Compulsive Disorder-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

  • $ 2000
  • Industry report
  • November 2016
  • by Delve Insight

DelveInsight’s Report, “Obsessive-Compulsive Disorder-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, ...

 Obsessive-Compulsive Disorder-Pipeline Insights, 2016

Obsessive-Compulsive Disorder-Pipeline Insights, 2016

  • $ 1250
  • Industry report
  • November 2016
  • by Delve Insight

DelveInsight’s, “ Obsessive-Compulsive Disorder-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Obsessive-Compulsive ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.